A[bedi]{.smallcaps}-V[alugerdi]{.smallcaps}, M., N[ilsson]{.smallcaps}, C., Z[argari]{.smallcaps}, A., G[haribdoost]{.smallcaps}, F., D[e]{.smallcaps} P[ierre]{.smallcaps}, J.W. and H[assan]{.smallcaps}, M. Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice, 238

A[bud]{.smallcaps}-M[endoza]{.smallcaps}, C. *see* V[igna]{.smallcaps}-P[érez]{.smallcaps}, M.

A[gace]{.smallcaps}, W.W. *see* J[ohansson]{.smallcaps}, C.

A[gnholt]{.smallcaps}, J. *see* K[elsen]{.smallcaps}, J.

A[guilar]{.smallcaps}, L.D. *see* I[nfante]{.smallcaps}, E.

A[hlstedt]{.smallcaps}, I. *see* J[ohansson]{.smallcaps}, C.

A[kira]{.smallcaps}, S. *see* O[hkawara]{.smallcaps}, T.

A[lvarado]{.smallcaps}-S[ánchez]{.smallcaps}, B. *see* V[igna]{.smallcaps}-P[érez]{.smallcaps}, M.

A[nderson]{.smallcaps}, K.C. *see* M[aecker]{.smallcaps}, B.

A[nderson]{.smallcaps}, K.S. *see* M[aecker]{.smallcaps}, B.

A[nderson]{.smallcaps}, R. *see* T[intinger]{.smallcaps}, G.

A[ndresen]{.smallcaps}, L. *see* P[edersen]{.smallcaps}, G.

A[ntas]{.smallcaps}, P.R.Z. *see* F[ortes]{.smallcaps}, A.

A[oki]{.smallcaps}, I. *see* N[agahama]{.smallcaps}, K.

A[rabito]{.smallcaps}, E. *see* C[airo]{.smallcaps}, C.

A[rita]{.smallcaps}, N. *see* T[subaki]{.smallcaps}, T.

A[sahina]{.smallcaps}, A. *see* K[agami]{.smallcaps}, S.

A[saka]{.smallcaps}, M. *see* O[hkawara]{.smallcaps}, T.

A[shman]{.smallcaps}, R. *see* E[lahi]{.smallcaps}, S.

B[abaykina]{.smallcaps}, O.N. *see* T[alayev]{.smallcaps}, Y.Yu.

B[ailey]{.smallcaps}, A.S. *see* S[eneviratne]{.smallcaps}, S.L.

B[alk]{.smallcaps}, A.H.M.M. *see*[van]{.smallcaps} B[esouw]{.smallcaps}, N.M.

B[aranda]{.smallcaps}, L. *see* V[igna]{.smallcaps}-P[érez]{.smallcaps}, M.

B[eck]{.smallcaps}-S[chimmer]{.smallcaps}, B. *see* V[uichard]{.smallcaps}, D.

B[ergström]{.smallcaps}, S. *see* S[jöwall]{.smallcaps}, J.

v[on]{.smallcaps} B[ergwelt]{.smallcaps}-B[aildon]{.smallcaps}, M.S. *see* M[aecker]{.smallcaps}, B.

[van]{.smallcaps} B[esouw]{.smallcaps}, N.M., Z[uijderwijk]{.smallcaps}, J.M., V[aessen]{.smallcaps}, L.M.B., B[alk]{.smallcaps}, A.H.M.M., M[aat]{.smallcaps}, A.P.W.M., [van]{.smallcaps} d[er]{.smallcaps} M[eide]{.smallcaps}, P.H. and W[eimar]{.smallcaps}, W. The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation, 534

B[iezeveld]{.smallcaps}, M.H., v[an]{.smallcaps} M[ierlo]{.smallcaps}, G., L[utter]{.smallcaps}, R., K[uipers]{.smallcaps}, I.M., D[ekker]{.smallcaps}, T., H[ack]{.smallcaps}, C.E., N[ewburger]{.smallcaps}, J.W. and K[uijpers]{.smallcaps}, T.W. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases, 183

B[ingemann]{.smallcaps}, T. *see* K[night]{.smallcaps}, A.K.

B[lack]{.smallcaps}, A.P. *see* S[eneviratne]{.smallcaps}, S.L.

B[loomingdale]{.smallcaps}, K.L. *see* R[obertson]{.smallcaps}, M.J.

B[ooy]{.smallcaps}, C. *see* V[uichard]{.smallcaps}, D.

B[ouma]{.smallcaps}, G., C[oppens]{.smallcaps}, J.M.C., L[am]{.smallcaps}-T[se]{.smallcaps}, W.-K., L[uini]{.smallcaps}, W., S[intnicolaas]{.smallcaps}, K., L[evering]{.smallcaps}, W.H., S[ozzani]{.smallcaps}, S., D[rexhage]{.smallcaps}, H.A. and V[ersnel]{.smallcaps}, M.A. An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes, 509

B[runetti]{.smallcaps}, E. *see* C[airo]{.smallcaps}, C.

B[ruschi]{.smallcaps}, M. *see* M[usante]{.smallcaps}, L.

B[rynskov]{.smallcaps}, J. *see* P[edersen]{.smallcaps}, G.

C[airo]{.smallcaps}, C., A[rabito]{.smallcaps}, E., L[andi]{.smallcaps}, F., C[asati]{.smallcaps}, A., B[runetti]{.smallcaps}, E., M[ancino]{.smallcaps}, G. and G[alli]{.smallcaps}, E. Analysis of circulating γδ^+^ T cells in children affected by IgE-associated and non-IgE-associated allergic atopic eczema/dermatitis syndrome, 116

C[alvani]{.smallcaps}, N. *see* C[lynes]{.smallcaps}, R.

C[alvano]{.smallcaps}, S.E. *see* W[ittebole]{.smallcaps}, X.

C[amussi]{.smallcaps}, G. *see* M[usante]{.smallcaps}, L.

C[andiano]{.smallcaps}, G. *see* M[usante]{.smallcaps}, L.

C[arlebach]{.smallcaps}, M. *see* T[owers]{.smallcaps}, R.

C[arlsson]{.smallcaps}, A. *see* S[jöwall]{.smallcaps}, J.

C[arnemolla]{.smallcaps}, B. *see* M[usante]{.smallcaps}, L.

C[arraro]{.smallcaps}, M. *see* M[usante]{.smallcaps}, L.

C[asati]{.smallcaps}, A. *see* C[airo]{.smallcaps}, C.

C[hai]{.smallcaps}, H.L. *see* N[agahama]{.smallcaps}, K.

C[hen]{.smallcaps}, Z.L. *see* W[ang]{.smallcaps}, H.W.

C[lancy]{.smallcaps}, R. *see* E[lahi]{.smallcaps}, S.

C[lynes]{.smallcaps}, R., C[alvani]{.smallcaps}, N., C[roker]{.smallcaps}, B.P. and R[ichards]{.smallcaps}, H.B. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors, 230

C[ole]{.smallcaps}, D. *see* W[ang]{.smallcaps}, H.W.

C[ole]{.smallcaps}, L. *see* K[night]{.smallcaps}, A.K.

C[oppens]{.smallcaps}, J.M.C. *see* B[ouma]{.smallcaps}, G.

C[oyle]{.smallcaps}, S.M. *see* W[ittebole]{.smallcaps}, X.

C[roker]{.smallcaps}, B.P. *see* C[lynes]{.smallcaps}, R.

C[uevas]{.smallcaps}-O[rta]{.smallcaps}, E. *see* V[igna]{.smallcaps}-P[érez]{.smallcaps}, M.

C[unha]{.smallcaps}, K.S. *see* F[ortes]{.smallcaps}, A.

C[unningham]{.smallcaps}-R[undles]{.smallcaps}, C. *see* K[night]{.smallcaps}, A.K.

D[ahlerup]{.smallcaps}, J.F. *see* K[elsen]{.smallcaps}, J.

D[ainty]{.smallcaps}, S.J. *see* P[leguezuelos]{.smallcaps}, O.

D[alcolmo]{.smallcaps}, M. *see* F[ortes]{.smallcaps}, A.

D[e]{.smallcaps} P[ierre]{.smallcaps}, J.W. *see* A[bedi]{.smallcaps}-V[alugerdi]{.smallcaps}, M.

D[ekker]{.smallcaps}, T. *see* B[iezeveld]{.smallcaps}, M.H.

D[iana]{.smallcaps}, J., V[incent]{.smallcaps}, C., P[eyron]{.smallcaps}, F., P[icot]{.smallcaps}, S., S[chmitt]{.smallcaps}, D. and P[ersat]{.smallcaps}, F. *Toxoplasma gondii* regulates recruitment and migration of human dendritic cells via different soluble secreted factors, 475

v[an]{.smallcaps} D[ijk]{.smallcaps}, J.E. *see* M[alago]{.smallcaps}, J.J.

D[rexhage]{.smallcaps}, H.A. *see* B[ouma]{.smallcaps}, G.

D[ubljevic]{.smallcaps}, V. *see* L[in]{.smallcaps}, J.L.J.

E[kerfelt]{.smallcaps}, C. *see* S[jöwall]{.smallcaps}, J.

E[lahi]{.smallcaps}, S., P[ang]{.smallcaps}, G., A[shman]{.smallcaps}, R. and C[lancy]{.smallcaps}, R. Enhanced clearance of *Candida albicans* from the oral cavities of mice following oral administration of *Lactobacillus acidophilus*, 29

E[rnerudh]{.smallcaps}, J. *see* S[jöwall]{.smallcaps}, J.

F[ang]{.smallcaps}, Y.T. *see* L[in]{.smallcaps}, Y.S.

F[incke]{.smallcaps}, J.E. *see* L[in]{.smallcaps}, W.L.

F[lores]{.smallcaps}-R[omo]{.smallcaps}, L. *see* P[aez]{.smallcaps}, A.

F[orsberg]{.smallcaps}, P. *see* S[jöwall]{.smallcaps}, J.

F[ortes]{.smallcaps}, A., P[ereira]{.smallcaps}, K., A[ntas]{.smallcaps}, P.R.Z., F[ranken]{.smallcaps}, C.L.M.C., D[alcolmo]{.smallcaps}, M., R[ibeiro]{.smallcaps}-C[arvalho]{.smallcaps}, M.M., C[unha]{.smallcaps}, K.S. G[eluk]{.smallcaps}, A., K[ritski]{.smallcaps}, A., K[olk]{.smallcaps}, A., K[latser]{.smallcaps}, P., S[arno]{.smallcaps}, E.N., O[ttenhoff]{.smallcaps}, T.H.M. and S[ampaio]{.smallcaps}, E.P. Detection of *in vitro* interferon-γ and serum tumour necrosis factor-α in multidrug-resistant tuberculosis patients, 541

F[ranken]{.smallcaps}, C.L.M.C. *see* F[ortes]{.smallcaps}, A.

F[ritzler]{.smallcaps}, M.J. *see* L[in]{.smallcaps}, J.L.J.

F[u]{.smallcaps}, N. *see* W[ang]{.smallcaps}, H.W.

F[ujii]{.smallcaps}, Y.R. *see* I[to]{.smallcaps}, M.

F[urubacka]{.smallcaps}, S. *see* J[ohansson]{.smallcaps}, C.

F[urukawa]{.smallcaps}, S. *see* M[atsubara]{.smallcaps}, T.

G[abay]{.smallcaps}, G. *see* T[owers]{.smallcaps}, R.

G[alli]{.smallcaps}, E. *see* C[airo]{.smallcaps}, C.

G[anter]{.smallcaps}, M.T. *see* V[uichard]{.smallcaps}, D.

G[aughan]{.smallcaps}, J. *see* L[in]{.smallcaps}, W.L.

G[elfand]{.smallcaps}, E.W. *see* S[ingh]{.smallcaps}, B.

G[eluk]{.smallcaps}, A. *see* F[ortes]{.smallcaps}, A.

G[erstoft]{.smallcaps}, J. *see* O[strowski]{.smallcaps}, S.R.

G[haribdoost]{.smallcaps}, F. *see* A[bedi]{.smallcaps}-V[alugerdi]{.smallcaps}, M.

G[higgeri]{.smallcaps}, G.M. *see* M[usante]{.smallcaps}, L.

G[iampuzzi]{.smallcaps}, M. *see* M[usante]{.smallcaps}, L.

G[icquel]{.smallcaps}, B. *see* I[nfante]{.smallcaps}, E.

G[irard]{.smallcaps}, D. *see* P[elletier]{.smallcaps}, M.

G[oberna]{.smallcaps}, R. *see* N[ajib]{.smallcaps}, S.

G[oldman]{.smallcaps}, M. *see* M[archant]{.smallcaps}, A.

G[onzález]{.smallcaps}-A[maro]{.smallcaps}, R. *see* V[igna]{.smallcaps}-P[érez]{.smallcaps}, M.

G[oshima]{.smallcaps}, M. *see* W[ittebole]{.smallcaps}, X.

G[oto]{.smallcaps}, D. *see* O[hnishi]{.smallcaps}, Y.

G[reen]{.smallcaps}, M.R.J., K[ennell]{.smallcaps}, A.S.M., L[arche]{.smallcaps}, M.J., S[eifert]{.smallcaps}, M.H., I[senberg]{.smallcaps}, D.A. and S[alaman]{.smallcaps}, M.R. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients, 165

G[uevara]{.smallcaps}, J. *see* P[aez]{.smallcaps}, A.

H[ack]{.smallcaps}, C.E. *see* B[iezeveld]{.smallcaps}, M.H.

H[äggqvist]{.smallcaps}, B. and H[ultman]{.smallcaps}, P. Interleukin-10 in murine metal-induced systemic autoimmunity, 422

H[amilton]{.smallcaps}, J.A. *see* S[kinner]{.smallcaps}, N.A.

H[anamoto]{.smallcaps}, H. *see* T[subaki]{.smallcaps}, T.

H[anda]{.smallcaps}, K. *see* M[itsuyama]{.smallcaps}, K.

H[arada]{.smallcaps}, K. *see* M[itsuyama]{.smallcaps}, K.

H[assan]{.smallcaps}, M. *see* A[bedi]{.smallcaps}-V[alugerdi]{.smallcaps}, M.

H[ayashi]{.smallcaps}, T. *see* I[to]{.smallcaps}, M.

H[ellmark]{.smallcaps}, T. *see* O[hlsson]{.smallcaps}, S.

H[ewinson]{.smallcaps}, R.G. *see* H[ope]{.smallcaps}, J.C.

H[ickman]{.smallcaps}-D[avis]{.smallcaps}, J.M. *see* L[ang]{.smallcaps}, J.D.

H[offmann]{.smallcaps}, H.J. *see* K[elsen]{.smallcaps}, J.

H[ope]{.smallcaps}, J.C., T[hom]{.smallcaps}, M.L., V[illarreal]{.smallcaps}-R[amos]{.smallcaps}, B., V[ordermeier]{.smallcaps}, H.M., H[ewinson]{.smallcaps}, R.G. and H[oward]{.smallcaps}, C.J. Exposure to *Mycobacterium avium* induces low-level protection from *Mycobacterium bovis* infection but compromises diagnosis of disease in cattle, 432

H[örnquist]{.smallcaps}, E.H. *see*Ü[hman]{.smallcaps}, L.

H[osokawa]{.smallcaps}, I. *see* H[osokawa]{.smallcaps}, Y.

H[osokawa]{.smallcaps}, Y., H[osokawa]{.smallcaps}, I., O[zaki]{.smallcaps}, K., N[akae]{.smallcaps}, H., M[urakami]{.smallcaps}, K., M[iyake]{.smallcaps}, Y. and M[atsuo]{.smallcaps}, T. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease, 467

H[oward]{.smallcaps}, C.J. *see* H[ope]{.smallcaps}, J.C.

H[ui]{.smallcaps}, D.S.C *see* W[ong]{.smallcaps}, C.K

H[ultgren]{.smallcaps}, O.H. *see*Ü[hman]{.smallcaps}, L.

H[ultman]{.smallcaps}, P. *see* H[äggqvist]{.smallcaps}, B.

H[vas]{.smallcaps}, C.L. *see* K[elsen]{.smallcaps}, J.

H[wa]{.smallcaps}, K.Y. *see* L[in]{.smallcaps}, Y.S.

I[chiyama]{.smallcaps}, T. *see* M[atsubara]{.smallcaps}, T.

I[nfante]{.smallcaps}, E., A[guilar]{.smallcaps}, L.D., G[icquel]{.smallcaps}, B. and P[ando]{.smallcaps}, R.H. Immunogenicity and protective efficacy of the *Mycobacterium tuberculosis fadD26* mutant, 21

I[p]{.smallcaps}, W.K *see* W[ong]{.smallcaps}, C.K

I[senberg]{.smallcaps}, D.A. see G[reen]{.smallcaps}, M.R.J.

I[shiguro]{.smallcaps}, Y. *see* O[hkawara]{.smallcaps}, T.

I[shihara]{.smallcaps}, Y. *see* I[wata]{.smallcaps}, T.

I[shii]{.smallcaps}, M. *see* K[obayashi]{.smallcaps}, K.

I[to]{.smallcaps}, M., O[moto]{.smallcaps}, S., K[ato]{.smallcaps}, Y., H[ayashi]{.smallcaps}, T., M[ori]{.smallcaps}, N. and F[ujii]{.smallcaps}, Y.R. *In vivo* tumouricidal effects of LAD-1 monoclonal antibody on murine RL-male-1 lymphoma mediated by enhanced phagocytosis, 54

I[toh]{.smallcaps}, S. *see* O[hnishi]{.smallcaps}, Y.

I[wanaga]{.smallcaps}, T. *see* O[hkawara]{.smallcaps}, T.

I[wata]{.smallcaps}, T., M[itani]{.smallcaps}, A., I[shihara]{.smallcaps}, Y., T[anaka]{.smallcaps}, S., Y[amamoto]{.smallcaps}, G., K[ikuchi]{.smallcaps}, T., N[aganawa]{.smallcaps}, T., M[atsumura]{.smallcaps}, Y., S[uga]{.smallcaps}, T., K[oide]{.smallcaps}, M., S[obue]{.smallcaps}, T., S[uzuki]{.smallcaps}, T. and N[oguchi]{.smallcaps}, T. *Actinobacillus actinomycetemcomitans* Y4 capsular polysaccharide induces IL-1β mRNA expression through the JNK pathway in differentiated THP-1 cells, 261

J[iang]{.smallcaps}, W.Z. *see* W[ang]{.smallcaps}, H.W.

J[in]{.smallcaps}, H.T. *see* W[ang]{.smallcaps}, H.W.

J[in]{.smallcaps}, N.Y. *see* W[ang]{.smallcaps}, H.W.

J[obin]{.smallcaps}, C. *see* K[im]{.smallcaps}, J.S.

J[ohansson]{.smallcaps}, C., A[hlstedt]{.smallcaps}, I., F[urubacka]{.smallcaps}, S., J[ohnsson]{.smallcaps}, E., A[gace]{.smallcaps}, W.W. and Q[uiding]{.smallcaps}-J[ärbrink]{.smallcaps}, M. Differential expression of chemokine receptors on human IgA+ and IgG+ B cells, 279

J[ohnsson]{.smallcaps}, E. *see* J[ohansson]{.smallcaps}, C.

J[ones]{.smallcaps}, L. *see* S[eneviratne]{.smallcaps}, S.L.

K[agami]{.smallcaps}, S., S[aeki]{.smallcaps}, H., K[omine]{.smallcaps}, M., K[akinuma]{.smallcaps}, T., T[sunemi]{.smallcaps}, Y., N[akamura]{.smallcaps}, K., S[asaki]{.smallcaps}, K., A[sahina]{.smallcaps}, A. and T[amaki]{.smallcaps}, K. Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells, 459

K[akinuma]{.smallcaps}, T. *see* K[agami]{.smallcaps}, S.

K[amogawa]{.smallcaps}, J. *see* T[subaki]{.smallcaps}, T.

K[anno]{.smallcaps}, A. *see* K[obayashi]{.smallcaps}, K.

K[anzaki]{.smallcaps}, S. *see* N[agahama]{.smallcaps}, K.

K[apas]{.smallcaps}, S. *see* P[leguezuelos]{.smallcaps}, O.

K[ato]{.smallcaps}, Y. *see* I[to]{.smallcaps}, M.

K[atzenstein]{.smallcaps}, T.L. *see* O[strowski]{.smallcaps}, S.R.

K[aushik]{.smallcaps}, S. *see* V[ajpayee]{.smallcaps}, M.

K[elsen]{.smallcaps}, J., A[gnholt]{.smallcaps}, J., H[offmann]{.smallcaps}, H.J., R[ømer]{.smallcaps}, J.L., H[vas]{.smallcaps}, C.L. and D[ahlerup]{.smallcaps}, J.F. FoxP3^+^CD4^+^CD25^+^ T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn\'s disease, 549

K[ennell]{.smallcaps}, A.S.M. see G[reen]{.smallcaps}, M.R.J.

K[ikuchi]{.smallcaps}, T. *see* I[wata]{.smallcaps}, T.

K[ikumoto]{.smallcaps}, Y. *see* K[obayashi]{.smallcaps}, K.

K[im]{.smallcaps}, J.S., N[arula]{.smallcaps}, A.S. and J[obin]{.smallcaps}, C. *Salvia miltiorrhiza* water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-κB signalling in intestinal epithelial cells, 288

K[ita]{.smallcaps}, A. *see* S[aitoh]{.smallcaps}, O.

K[latser]{.smallcaps}, P. *see* F[ortes]{.smallcaps}, A.

K[lein]{.smallcaps}, A. *see* T[owers]{.smallcaps}, R.

K[night]{.smallcaps}, A.K., B[ingemann]{.smallcaps}, T., C[ole]{.smallcaps}, L. and C[unningham]{.smallcaps}-R[undles]{.smallcaps}, C. Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency, 333

K[o]{.smallcaps}, F.W.S *see* W[ong]{.smallcaps}, C.K.

K[obayashi]{.smallcaps}, K., I[shii]{.smallcaps}, M., S[hiina]{.smallcaps}, M., U[eno]{.smallcaps}, Y., K[ondo]{.smallcaps}, Y., K[anno]{.smallcaps}, A., M[iyazaki]{.smallcaps}, Y., Y[amamoto]{.smallcaps}, T., K[obayashi]{.smallcaps}, T., N[iitsuma]{.smallcaps}, H., K[ikumoto]{.smallcaps}, Y., T[akizawa]{.smallcaps} H. and S[himosegawa]{.smallcaps}, T. Interferon-γ is produced by CD8^+^ T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus loss, 81

K[obayashi]{.smallcaps}, T. *see* K[obayashi]{.smallcaps}, K.

K[oide]{.smallcaps}, M. *see* I[wata]{.smallcaps}, T.

K[olk]{.smallcaps}, A. *see* F[ortes]{.smallcaps}, A.

K[omaroff]{.smallcaps}, A.L. *see* R[obertson]{.smallcaps}, M.J.

K[omine]{.smallcaps}, M. *see* K[agami]{.smallcaps}, S.

K[ondo]{.smallcaps}, Y. *see* K[obayashi]{.smallcaps}, K.

K[oninkx]{.smallcaps}, J.F.J.G. *see* M[alago]{.smallcaps}, J.J.

K[ritski]{.smallcaps}, A. *see* F[ORTES]{.smallcaps}, A.

K[uijpers]{.smallcaps}, T.W. *see* B[iezeveld]{.smallcaps}, M.H.

K[uipers]{.smallcaps}, I.M. *see* B[iezeveld]{.smallcaps}, M.H.

K[umar]{.smallcaps}, A. *see* W[ittebole]{.smallcaps}, X.

K[uo]{.smallcaps}, Y.M. *see* L[in]{.smallcaps}, Y.S.

K[uwahara]{.smallcaps}, H. *see* S[aitoh]{.smallcaps}, O.

L[am]{.smallcaps}, C.W.K. *see* W[ong]{.smallcaps}, C.K

L[amprecht]{.smallcaps}, P. Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides, 201

L[am]{.smallcaps}-T[se]{.smallcaps}, W.-K. *see* B[OUMA]{.smallcaps}, G.

L[andi]{.smallcaps}, F. *see* C[airo]{.smallcaps}, C.

L[ang]{.smallcaps}, J.D. and H[ickman]{.smallcaps}-D[avis]{.smallcaps}, J.M. One-hit, two-hit ... is there really any benefit? 211

L[arche]{.smallcaps}, M.J. see G[reen]{.smallcaps}, M.R.J.

L[ei]{.smallcaps}, H.Y. *see* L[in]{.smallcaps}, Y.S.

L[evering]{.smallcaps}, W.H. *see* B[ouma]{.smallcaps}, G.

L[iao]{.smallcaps}, P.C. *see* L[in]{.smallcaps}, Y.S.

v[an]{.smallcaps} L[iere]{.smallcaps}, E.A. *see* M[alago]{.smallcaps}, J.J.

L[in]{.smallcaps}, C.F. *see* L[in]{.smallcaps}, Y.S.

L[in]{.smallcaps}, J.L.J., D[ubljevic]{.smallcaps}, V., F[ritzler]{.smallcaps}, M.J. and T[oh]{.smallcaps}, B.-H. Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus, 155

L[in]{.smallcaps}, W.L., F[incke]{.smallcaps}, J.E., S[harer]{.smallcaps}, L.R., M[onos]{.smallcaps}, D.S., L[u]{.smallcaps}, S., G[aughan]{.smallcaps}, J., P[latsoucas]{.smallcaps}, C.D. and O[leszak]{.smallcaps}, E.L. Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical β-chain T-cell receptor transcripts, 338

L[in]{.smallcaps}, Y.S., L[in]{.smallcaps}, C.F., F[ang]{.smallcaps}, Y.T., K[uo]{.smallcaps}, Y.M., L[iao]{.smallcaps}, P.C., Y[eh]{.smallcaps}, T.M., H[wa]{.smallcaps}, K.Y., S[hieh]{.smallcaps}, C.C.K., Y[en]{.smallcaps}, J.H., W[ang]{.smallcaps}, H.J., S[u]{.smallcaps}, I.J. and L[ei]{.smallcaps}, H.Y. Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity, 500

L[omunova]{.smallcaps}, M.A. *see* T[alayev]{.smallcaps}, Y.Yu.

L[owry]{.smallcaps}, S.F. *see* W[ittebole]{.smallcaps}, X.

L[u]{.smallcaps}, S. *see* L[in]{.smallcaps}, W.L.

L[uini]{.smallcaps}, W. *see* B[ouma]{.smallcaps}, G.

L[un]{.smallcaps}, S.W.M. *see* W[ong]{.smallcaps}, C.K

L[utter]{.smallcaps}, R. *see* B[iezeveld]{.smallcaps}, M.H.

M[aat]{.smallcaps}, A.P.W.M. *see*[van]{.smallcaps} B[esouw]{.smallcaps}, N.M.

M[ac]{.smallcaps}I[saac]{.smallcaps}, C.M. *see* S[kinner]{.smallcaps}, N.A.

M[ackin]{.smallcaps}, G.A. *see* R[obertson]{.smallcaps}, M.J.

M[aecker]{.smallcaps}, B., v[on]{.smallcaps} B[ergwelt]{.smallcaps}-B[aildon]{.smallcaps}, M.S., A[nderson]{.smallcaps}, K.S., V[onderheide]{.smallcaps}, R.H., A[nderson]{.smallcaps}, K.C., N[adler]{.smallcaps}, L.M. and S[CHULTZE]{.smallcaps}, J.L. Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients, 558

M[alago]{.smallcaps}, J.J., K[oninkx]{.smallcaps}, J.F.J.G., T[ooten]{.smallcaps}, P.C.J., v[an]{.smallcaps} L[iere]{.smallcaps}, E.A. and v[an]{.smallcaps} D[ijk]{.smallcaps}, J.E. Anti-inflammatory properties of heat shock protein 70 and butyrate on *Salmonella*-induced interleukin-8 secretion in enterocyte-like Caco-2 cells, 62

M[ancino]{.smallcaps}, G. *see* C[airo]{.smallcaps}, C.

M[archant]{.smallcaps}, A. and G[oldman]{.smallcaps}, M. T cell-mediated immune responses in human newborns: ready to learn?, 10

M[aru]{.smallcaps}, K. *see* N[agahama]{.smallcaps}, K.

M[assó]{.smallcaps}, F.A. *see* P[aez]{.smallcaps}, A.

M[asuda]{.smallcaps}, J. *see* M[ITSUYAMA]{.smallcaps}, K.

M[atsubara]{.smallcaps}, T., I[chiyama]{.smallcaps}, T. and F[urukawa]{.smallcaps}, S. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease, 381

M[atsumoto]{.smallcaps}, I. *see* O[hnishi]{.smallcaps}, Y.

M[atsumoto]{.smallcaps}, S. *see* M[itsuyama]{.smallcaps}, K.

M[atsumura]{.smallcaps}, Y. *see* I[wata]{.smallcaps}, T.

M[atsuo]{.smallcaps}, T. *see* H[osokawa]{.smallcaps}, Y.

M[atthiessen]{.smallcaps}, M.W. *see* P[edersen]{.smallcaps}, G.

[van]{.smallcaps} d[er]{.smallcaps} M[eide]{.smallcaps}, P.H. *see*[VAN]{.smallcaps} B[esouw]{.smallcaps}, N.M.

M[éndez]{.smallcaps}-C[ruz]{.smallcaps}, A.R. *see* P[aez]{.smallcaps}, A.

[van]{.smallcaps} M[ierlo]{.smallcaps}, G. *see* B[iezeveld]{.smallcaps}, M.H.

M[itani]{.smallcaps}, A. *see* I[wata]{.smallcaps}, T.

M[itsuyama]{.smallcaps}, K., S[uzuki]{.smallcaps}, A., M[atsumoto]{.smallcaps}, S., T[omiyasu]{.smallcaps}, N., T[akaki]{.smallcaps}, K., T[akedatsu]{.smallcaps}, H., M[asuda]{.smallcaps}, J., H[anda]{.smallcaps}, K., H[arada]{.smallcaps}, K., N[ishida]{.smallcaps}, H., T[oyonaga]{.smallcaps}, A. and S[ata]{.smallcaps}, M. Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis, 130

M[iura]{.smallcaps}, S. *see* N[agahama]{.smallcaps}, K.

M[iyake]{.smallcaps}, Y. *see* H[osokawa]{.smallcaps}, Y.

M[iyashita]{.smallcaps}, K. *see* O[hkawara]{.smallcaps}, T.

M[iyazaki]{.smallcaps}, Y. *see* K[obayashi]{.smallcaps}, K.

M[izutori]{.smallcaps}, Y. *see* S[aitoh]{.smallcaps}, O.

M[onos]{.smallcaps}, D.S. *see* L[in]{.smallcaps}, W.L.

M[ontaÑo]{.smallcaps}, L.F. *see* P[aez]{.smallcaps}, A.

M[oreno]{.smallcaps}-V[aldés]{.smallcaps}, R. *see* V[igna]{.smallcaps}-P[érez]{.smallcaps}, M.

M[ori]{.smallcaps}, N. *see* I[to]{.smallcaps}, M.

M[outsopoulos]{.smallcaps}, H.M. *see* S[tathopoulou]{.smallcaps}, E.A.

M[uniain]{.smallcaps}, M.A. *see* N[ajib]{.smallcaps}, S.

M[urakami]{.smallcaps}, K. *see* H[osokawa]{.smallcaps}, Y.

M[usante]{.smallcaps}, L., C[andiano]{.smallcaps}, G., B[ruschi]{.smallcaps}, M., S[antucci]{.smallcaps}, L., C[arnemolla]{.smallcaps}, B., O[recchia]{.smallcaps}, P., G[iampuzzi]{.smallcaps}, M., Z[ennaro]{.smallcaps}, C., S[anna]{.smallcaps}-C[herchi]{.smallcaps}, S., C[arraro]{.smallcaps}, M., O[leggini]{.smallcaps}, R., C[amussi]{.smallcaps}, G., P[erfumo]{.smallcaps}, F. and G[higgeri]{.smallcaps}, G.M. Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome, 491

N[adler]{.smallcaps}, L.M. *see* M[aecker]{.smallcaps}, B.

N[aftali]{.smallcaps}, T. *see* T[owers]{.smallcaps}, R.

N[agahama]{.smallcaps}, K., M[aru]{.smallcaps}, K., K[anzaki]{.smallcaps}, S., C[hai]{.smallcaps}, H.L., N[akai]{.smallcaps}, T., M[iura]{.smallcaps}, S., Y[amaguchi]{.smallcaps}, A., Y[amanaka]{.smallcaps}, S., N[agashima]{.smallcaps}, Y. and A[oki]{.smallcaps}, I. Possible role of autoantibodies against nephrin in an experimental model of chronic graft-*versus*-host disease, 215

N[aganawa]{.smallcaps}, T. *see* I[wata]{.smallcaps}, T.

N[agashima]{.smallcaps}, Y. *see* N[agahama]{.smallcaps}, K.

N[agayama]{.smallcaps}, Y. *see* S[aitoh]{.smallcaps}, O.

N[ajib]{.smallcaps}, S., R[odríguez]{.smallcaps}-B[año]{.smallcaps}, J., R[íos]{.smallcaps}, M.J., M[uniain]{.smallcaps}, M.A., G[oberna]{.smallcaps}, R. and S[ánchez]{.smallcaps}-M[argalet]{.smallcaps}, V. Sam68 is tyrosine phosphorylated and recruited to signalling in peripheral blood mononuclear cells from HIV infected patients, 518

N[akae]{.smallcaps}, H. *see* H[osokawa]{.smallcaps}, Y.

N[akai]{.smallcaps}, T. *see* N[agahama]{.smallcaps}, K.

N[akamura]{.smallcaps}, K. *see* K[agami]{.smallcaps}, S.

N[akata]{.smallcaps}, S. *see* T[subaki]{.smallcaps}, T.

N[arula]{.smallcaps}, A.S. *see* K[im]{.smallcaps}, J.S.

N[ewburger]{.smallcaps}, J.W. *see* B[iezeveld]{.smallcaps}, M.H.

N[ihiwaki]{.smallcaps}, M. *see* O[hkawara]{.smallcaps}, T.

N[iitsuma]{.smallcaps}, H. *see* K[obayashi]{.smallcaps}, K.

N[ikonova]{.smallcaps}, M.F. *see* T[alayev]{.smallcaps}, Y.Yu.

N[ilsson]{.smallcaps}, C. *see* A[bedi]{.smallcaps}-V[alugerdi]{.smallcaps}, M.

N[ishida]{.smallcaps}, H. *see* M[itsuyama]{.smallcaps}, K.

N[ishihira]{.smallcaps}, J. *see* O[hkawara]{.smallcaps}, T.

N[oguchi]{.smallcaps}, T. *see* I[wata]{.smallcaps}, T.

N[ose]{.smallcaps}, M. *see* T[subaki]{.smallcaps}, T.

N[ovis]{.smallcaps}, B. *see* T[owers]{.smallcaps}, R.

O[dermatt]{.smallcaps}, B. *see* P[robst]{.smallcaps}, H.C.

O[gg]{.smallcaps}, G.S. *see* S[eneviratne]{.smallcaps}, S.L.

O[hkawara]{.smallcaps}, T., T[akeda]{.smallcaps}, H., N[ishihira]{.smallcaps}, J., M[iyashita]{.smallcaps}, K., N[ihiwaki]{.smallcaps}, M., I[shiguro]{.smallcaps}, Y., T[akeda]{.smallcaps}, K., A[kira]{.smallcaps}, S., I[wanaga]{.smallcaps}, T., S[ugiyama]{.smallcaps}, T. and A[saka]{.smallcaps}, M. Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium-induced colitis in Toll-like receptor 4 knockout mice, 412

O[hlsson]{.smallcaps}, S., H[ellmark]{.smallcaps}, T., P[ieters]{.smallcaps}, K., S[turfelt]{.smallcaps}, G., W[ieslander]{.smallcaps}, J. and S[egelmark]{.smallcaps}, M. Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis, 174

O[hnishi]{.smallcaps}, Y., T[sutsumi]{.smallcaps}, A., G[oto]{.smallcaps}, D., I[toh]{.smallcaps}, S., M[atsumoto]{.smallcaps}, I., T[aniguchi]{.smallcaps}, M. and S[umida]{.smallcaps}, T. TCR Vα14^+^ natural killer T cells function as effector T cells in mice with collagen-induced arthritis, 47

O[leggini]{.smallcaps}, R. *see* M[usante]{.smallcaps}, L.

O[leszak]{.smallcaps}, E.L. *see* L[in]{.smallcaps}, W.L.

O[moto]{.smallcaps}, S. *see* I[to]{.smallcaps}, M.

O[recchia]{.smallcaps}, P. *see* M[usante]{.smallcaps}, L.

O[strowski]{.smallcaps}, S.R., U[llum]{.smallcaps}, H., P[edersen]{.smallcaps}, B.K., G[erstoft]{.smallcaps}, J. and K[atzenstein]{.smallcaps}, T.L. 2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy, 526

O[ttenhoff]{.smallcaps}, T.H.M. *see* F[ortes]{.smallcaps}, A.

O[zaki]{.smallcaps}, K. *see* H[osokawa]{.smallcaps}, Y.

P[abst]{.smallcaps}, R. *see* S[ingh]{.smallcaps}, B.

P[aez]{.smallcaps}, A., M[éndez]{.smallcaps}-C[ruz]{.smallcaps}, A.R., V[arela]{.smallcaps}, E., R[odriguez]{.smallcaps}, E., G[uevara]{.smallcaps}, J., F[lores]{.smallcaps}-R[omo]{.smallcaps}, L., M[ontaño]{.smallcaps}, L.F. and M[assó]{.smallcaps}, F.A. HUVECs from newborns with a strong family history of myocardial infarction overexpress adhesion molecules and react abnormally to stimulating agents, 449

P[ando]{.smallcaps}, R.H. *see* I[nfante]{.smallcaps}, E.

P[ang]{.smallcaps}, G. *see* E[lahi]{.smallcaps}, S.

P[aredes]{.smallcaps}-S[aharopulos]{.smallcaps}, O. *see* V[igna]{.smallcaps}-P[érez]{.smallcaps}, M.

P[asch]{.smallcaps}, T. *see* V[uichard]{.smallcaps}, D.

P[edersen]{.smallcaps}, B.K. *see* O[strowski]{.smallcaps}, S.R.

P[edersen]{.smallcaps}, G., A[ndresen]{.smallcaps}, L., M[atthiessen]{.smallcaps}, M.W., R[ask]{.smallcaps}-M[adsen]{.smallcaps}, J. and B[rynskov]{.smallcaps}, J. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium, 298

P[elletier]{.smallcaps}, M. and G[irard]{.smallcaps}, D. Interleukin-15 increases neutrophil adhesion onto human respiratory epithelial A549 cells and attracts neutrophils *in vivo*, 315

P[ennec]{.smallcaps}, Y.-L. *see* Y[ouinou]{.smallcaps}, P.

P[ereira]{.smallcaps}, K. *see* F[ortes]{.smallcaps}, A.

P[erfumo]{.smallcaps}, F. *see* M[usante]{.smallcaps}, L.

P[ers]{.smallcaps}, J.-O. *see* Y[ouinou]{.smallcaps}, P.

P[ersat]{.smallcaps}, F. *see* D[iana]{.smallcaps}, J.

P[eyron]{.smallcaps}, F. *see* D[iana]{.smallcaps}, J.

P[icot]{.smallcaps}, S. *see* D[iana]{.smallcaps}, J.

P[ieters]{.smallcaps}, K. *see* O[hlsson]{.smallcaps}, S.

P[latsoucas]{.smallcaps}, C.D. *see* L[in]{.smallcaps}, W.L.

P[leguezuelos]{.smallcaps}, O., D[ainty]{.smallcaps}, S.J., K[apas]{.smallcaps}, S. and T[aylor]{.smallcaps}, J.J. A human oral keratinocyte cell line responds to human heat shock protein 60 through activation of ERK1/2 MAP kinases and up-regulation of IL-1β, 307

P[ortillo]{.smallcaps}-S[alazar]{.smallcaps}, H. *see* V[igna]{.smallcaps}-P[érez]{.smallcaps}, M.

P[robst]{.smallcaps}, H.C., T[schannen]{.smallcaps}, K., O[dermatt]{.smallcaps}, B., S[chwendener]{.smallcaps}, R., Z[inkernagel]{.smallcaps}, R.M. and V[an]{.smallcaps} D[en]{.smallcaps} B[roek]{.smallcaps}, M. Histological analysis of CD11c-DTR/GFP mice after *in vivo* depletion of dendritic cells, 398

Q[uiding]{.smallcaps}-J[ärbrink]{.smallcaps}, M. *see* Johansson, C.

R[ask]{.smallcaps}-M[adsen]{.smallcaps}, J. *see* P[edersen]{.smallcaps}, G.

R[eyes]{.smallcaps}, L. *see* V[uichard]{.smallcaps}, D.

R[ibeiro]{.smallcaps}-C[arvalho]{.smallcaps}, M.M. *see* F[ortes]{.smallcaps}, A.

R[ichards]{.smallcaps}, H.B. *see* C[lynes]{.smallcaps}, R.

R[ÍOS]{.smallcaps}, M.J. *see* N[ajib]{.smallcaps}, S.

R[itz]{.smallcaps}, J. *see* R[obertson]{.smallcaps}, M.J.

R[obertson]{.smallcaps}, M.J., S[chacterle]{.smallcaps}, R.S., M[ackin]{.smallcaps}, G.A., W[ilson]{.smallcaps}, S.N., B[loomingdale]{.smallcaps}, K.L., R[itz]{.smallcaps}, J. and K[omaroff]{.smallcaps}, A.L. Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression, 326

R[odríguez]{.smallcaps}-B[año]{.smallcaps}, J. *see* N[ajib]{.smallcaps}, S.

R[odriguez]{.smallcaps}, E. *see* P[aez]{.smallcaps}, A.

R[ømer]{.smallcaps}, J.L. *see* K[elsen]{.smallcaps}, J.

R[outsias]{.smallcaps}, J.G. *see* S[tathopoulou]{.smallcaps}, E.A.

S[accardi]{.smallcaps}, R. *see* T[yndall]{.smallcaps}, A.

S[aeki]{.smallcaps}, H. *see* K[agami]{.smallcaps}, S.

S[aitoh]{.smallcaps}, O., M[izutori]{.smallcaps}, Y., T[akamura]{.smallcaps}, N., Y[amasaki]{.smallcaps}, H., K[ita]{.smallcaps}, A., K[uwahara]{.smallcaps}, H. and N[agayama]{.smallcaps}, Y. Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor b, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice, 405

S[alaman]{.smallcaps}, M.R. see G[reen]{.smallcaps}, M.R.J.

S[ampaio]{.smallcaps}, E.P. *see* F[ortes]{.smallcaps}, A.

S[amuel]{.smallcaps}, R.V. *see* S[eneviratne]{.smallcaps}, S.L.

S[ánchez]{.smallcaps}-M[argalet]{.smallcaps}, V. *see* N[ajib]{.smallcaps}, S.

S[anna]{.smallcaps}-C[herchi]{.smallcaps}, S. *see* M[usante]{.smallcaps}, L.

S[antucci]{.smallcaps}, L. *see* M[usante]{.smallcaps}, L.

S[araux]{.smallcaps}, A. *see* Y[ouinou]{.smallcaps}, P.

S[arno]{.smallcaps}, E.N. *see* F[ortes]{.smallcaps}, A.

S[asaki]{.smallcaps}, K. *see* K[agami]{.smallcaps}, S.

S[ata]{.smallcaps}, M. *see* M[itsuyama]{.smallcaps}, K.

S[chacterle]{.smallcaps}, R.S. *see* R[obertson]{.smallcaps}, M.J.

S[chievella]{.smallcaps}, A. *see* Y[acyshyn]{.smallcaps}, B.R.

S[chimmer]{.smallcaps}, R.C. *see* V[uichard]{.smallcaps}, D.

S[chmitt]{.smallcaps}, D. *see* D[iana]{.smallcaps}, J.

S[chultze]{.smallcaps}, J.L. *see* M[aecker]{.smallcaps}, B.

S[chwendener]{.smallcaps}, R. *see* P[robst]{.smallcaps}, H.C.

S[egelmark]{.smallcaps}, M. *see* O[hlsson]{.smallcaps}, S.

S[eifert]{.smallcaps}, M.H. see G[reen]{.smallcaps}, M.R.J.

S[eneviratne]{.smallcaps}, S.L., J[ones]{.smallcaps}, L., B[ailey]{.smallcaps}, A.S., S[amuel]{.smallcaps}, R.V., B[lack]{.smallcaps}, A.P. and O[gg]{.smallcaps}, G.S. Interleukin-4 induced down-regulation of skin homing receptor expression by human viral-specific CD8^+^ T cells may contribute to atopic risk of cutaneous infection, 107

S[eth]{.smallcaps}, P. *see* V[ajpayee]{.smallcaps}, M.

S[ewell]{.smallcaps}, K.L. *see* Y[acyshyn]{.smallcaps}, B.R.

S[harer]{.smallcaps}, L.R. *see* L[in]{.smallcaps}, W.L.

S[hieh]{.smallcaps}, C.C.K. *see* L[in]{.smallcaps}, Y.S.

S[hiina]{.smallcaps}, M. *see* K[obayashi]{.smallcaps}, K.

S[himosegawa]{.smallcaps}, T. *see* K[obayashi]{.smallcaps}, K.

S[hinagawa]{.smallcaps}, K. *see* S[ingh]{.smallcaps}, B.

S[ingh]{.smallcaps}, B., S[hinagawa]{.smallcaps}, K., T[aube]{.smallcaps}, C., G[elfand]{.smallcaps}, E.W. and P[abst]{.smallcaps}, R. Strain-specific differences in perivascular inflammation in lungs in two murine models of allergic airway inflammation, 223

S[intnicolaas]{.smallcaps}, K. *see* B[ouma]{.smallcaps}, G.

S[jöwall]{.smallcaps}, J., C[arlsson]{.smallcaps}, A., V[aarala]{.smallcaps}, O., B[ergström]{.smallcaps}, S., E[rnerudh]{.smallcaps}, J., F[ORSBERG]{.smallcaps}, P. and E[kerfelt]{.smallcaps}, C. Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-α and interleukin-12 in asymptomatic individuals in response to live spirochetes, 89

S[kinner]{.smallcaps}, N.A., M[ac]{.smallcaps}I[saac]{.smallcaps}, C.M., H[amilton]{.smallcaps}, J.A. and V[isvanathan]{.smallcaps}, K. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14^dim^CD16^+^ monocytes in response to sepsis-related antigens, 270

S[mith]{.smallcaps}, T.J. Insights into the role of fibroblasts in human autoimmune diseases, 388

S[obue]{.smallcaps}, T. *see* I[wata]{.smallcaps}, T.

S[ozzani]{.smallcaps}, S. *see* B[ouma]{.smallcaps}, G.

S[reenivas]{.smallcaps}, V. *see* V[ajpayee]{.smallcaps}, M.

S[tathopoulou]{.smallcaps}, E.A., R[outsias]{.smallcaps}, J.G., S[tea]{.smallcaps}, E.A., M[outsopoulos]{.smallcaps}, H.M. and T[zioufas]{.smallcaps}, A.G. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein, 148

S[tea]{.smallcaps}, E.A. *see* S[tathopoulou]{.smallcaps}, E.A.

S[teel]{.smallcaps}, H.C. *see* T[intinger]{.smallcaps}, G.

S[turfelt]{.smallcaps}, G. *see* O[hlsson]{.smallcaps}, S.

S[u]{.smallcaps}, I.J. *see* L[in]{.smallcaps}, Y.S.

S[uga]{.smallcaps}, T. *see* I[wata]{.smallcaps}, T.

S[ugiyama]{.smallcaps}, T. *see* O[hkawara]{.smallcaps}, T.

S[umida]{.smallcaps}, T. *see* O[hnishi]{.smallcaps}, Y.

S[uter]{.smallcaps}, D. *see* V[uichard]{.smallcaps}, D.

S[uzuki]{.smallcaps}, A. *see* M[itsuyama]{.smallcaps}, K.

S[uzuki]{.smallcaps}, T. *see* I[wata]{.smallcaps}, T.

T[akaki]{.smallcaps}, K. *see* M[itsuyama]{.smallcaps}, K.

T[akamura]{.smallcaps}, N. *see* S[aitoh]{.smallcaps}, O.

T[akeda]{.smallcaps}, H. *see* O[hkawara]{.smallcaps}, T.

T[akeda]{.smallcaps}, K. *see* O[hkawara]{.smallcaps}, T.

T[akedatsu]{.smallcaps}, H. *see* M[itsuyama]{.smallcaps}, K.

T[akegawa]{.smallcaps}, S. *see* T[subaki]{.smallcaps}, T.

T[akizawa]{.smallcaps} H. *see* K[obayashi]{.smallcaps}, K.

T[akubo]{.smallcaps}, N. *see* T[subaki]{.smallcaps}, T.

T[alayev]{.smallcaps}, V.Yu., Z[aichenko]{.smallcaps}, I.Ye., B[abaykina]{.smallcaps}, O.N., L[omunova]{.smallcaps}, M.A., T[alayeva]{.smallcaps}, E.B. and N[ikonova]{.smallcaps} M.F. *Ex vivo* stimulation of cord blood mononuclear cells by dexamethasone and interleukin-7 results in the maturation of interferon-γ-secreting effector memory T cells, 440

T[alayeva]{.smallcaps}, E.B. *see* T[alayev]{.smallcaps}, Y.Yu.

T[amaki]{.smallcaps}, K. *see* K[agami]{.smallcaps}, S.

T[ami]{.smallcaps}, J.A. *see* Y[acyshyn]{.smallcaps}, B.R.

T[anaka]{.smallcaps}, S. *see* I[wata]{.smallcaps}, T.

T[aniguchi]{.smallcaps}, M. *see* O[hnishi]{.smallcaps}, Y.

T[aube]{.smallcaps}, C. *see* S[ingh]{.smallcaps}, B.

T[aylor]{.smallcaps}, J.J. *see* P[leguezuelos]{.smallcaps}, O.

T[hom]{.smallcaps}, M.L. *see* H[ope]{.smallcaps}, J.C.

T[intinger]{.smallcaps}, G., S[teel]{.smallcaps}, H.C. and A[nderson]{.smallcaps}, R. Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control, 191

T[oh]{.smallcaps}, B.-H. *see* L[in]{.smallcaps}, J.L.J.

T[omiyasu]{.smallcaps}, N. *see* M[itsuyama]{.smallcaps}, K.

T[ooten]{.smallcaps}, P.C.J. *see* M[alago]{.smallcaps}, J.J.

T[owers]{.smallcaps}, R., N[aftali]{.smallcaps}, T., G[abay]{.smallcaps}, G., C[arlebach]{.smallcaps}, M., K[lein]{.smallcaps}, A. and N[ovis]{.smallcaps}, B. High levels of glucocorticoid receptors in patients with active Crohn\'s disease may predict steroid resistance, 357

T[oyonaga]{.smallcaps}, A. *see* M[itsuyama]{.smallcaps}, K.

T[schannen]{.smallcaps}, K. *see* P[robst]{.smallcaps}, H.C.

T[subaki]{.smallcaps}, T., T[akegawa]{.smallcaps}, S., H[anamoto]{.smallcaps}, H., A[rita]{.smallcaps}, N., K[amogawa]{.smallcaps}, J., Y[amamoto]{.smallcaps}, H., T[akubo]{.smallcaps}, N., N[akata]{.smallcaps}, S., Y[amada]{.smallcaps}, K., Y[amamoto]{.smallcaps}, S., Y[oshie]{.smallcaps}, O. and N[ose]{.smallcaps}, M. Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts, 363

T[sunemi]{.smallcaps}, Y. *see* K[agami]{.smallcaps}, S.

T[sutsumi]{.smallcaps}, A. *see* O[hnishi]{.smallcaps}, Y.

T[yndall]{.smallcaps}, A. and S[accardi]{.smallcaps}, R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions, 1

T[zioufas]{.smallcaps}, A.G. *see* S[tathopoulou]{.smallcaps}, E.A.

U[eno]{.smallcaps}, Y. *see* K[obayashi]{.smallcaps}, K.

Ü[hman]{.smallcaps}, L., W[illÉn]{.smallcaps}, R., H[ultgren]{.smallcaps}, O.H. and H[örnquist]{.smallcaps}, E.H. Acellular *Bordetella pertussis* vaccine enhances mucosal interleukin-10 production, induces apoptosis of activated Th1 cells and attenuates colitis in Gαi2-deficient mice, 37

U[llum]{.smallcaps}, H. *see* O[strowski]{.smallcaps}, S.R.

V[aarala]{.smallcaps}, O. *see* S[jöwall]{.smallcaps}, J.

V[aessen]{.smallcaps}, L.M.B. *see*[van]{.smallcaps} B[esouw]{.smallcaps}, N.M.

V[ajpayee]{.smallcaps}, M., K[aushik]{.smallcaps}, S., S[reenivas]{.smallcaps}, V., W[ig]{.smallcaps}, N. and S[eth]{.smallcaps}, P. CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1-infected Indian population: treatment implications, 485

V[an]{.smallcaps} D[en]{.smallcaps} B[roek]{.smallcaps}, M. *see* P[robst]{.smallcaps}, H.C.

V[arela]{.smallcaps}, E. *see* P[aez]{.smallcaps}, A.

V[ersnel]{.smallcaps}, M.A. *see* B[ouma]{.smallcaps}, G.

V[igna]{.smallcaps}-P[érez]{.smallcaps}, M., A[bud]{.smallcaps}-M[endoza]{.smallcaps}, C., P[ortillo]{.smallcaps}-S[alazar]{.smallcaps}, H., A[lvarado]{.smallcaps}-S[ánchez]{.smallcaps}, B., C[uevas]{.smallcaps}-O[rta]{.smallcaps}, E., M[oreno]{.smallcaps}-V[aldés]{.smallcaps}, R., B[aranda]{.smallcaps}, L., P[aredes]{.smallcaps}-S[aharopulos]{.smallcaps}, O. and G[onzález]{.smallcaps}-A[maro]{.smallcaps}, R. Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis, 372

V[illarreal]{.smallcaps}-R[amos]{.smallcaps}, B. *see* H[ope]{.smallcaps}, J.C.

V[incent]{.smallcaps}, C. *see* D[iana]{.smallcaps}, J.

V[isvanathan]{.smallcaps}, K. *see* S[kinner]{.smallcaps}, N.A.

V[onderheide]{.smallcaps}, R.H. *see* M[aecker]{.smallcaps}, B.

V[ordermeier]{.smallcaps}, H.M. *see* H[ope]{.smallcaps}, J.C.

V[uichard]{.smallcaps}, D., G[anter]{.smallcaps}, M.T., S[chimmer]{.smallcaps}, R.C., S[uter]{.smallcaps}, D., B[ooy]{.smallcaps}, C., R[eyes]{.smallcaps}, L., P[asch]{.smallcaps}, T. and B[eck]{.smallcaps}-S[chimmer]{.smallcaps}, B. Hypoxia aggravates lipopolysaccharide-induced lung injury, 248

W[ang]{.smallcaps}, H.J. *see* L[in]{.smallcaps}, Y.S.

W[ang]{.smallcaps}, H.W., C[ole]{.smallcaps}, D., J[iang]{.smallcaps}, W.Z., J[in]{.smallcaps}, H.T., F[u]{.smallcaps}, N., C[hen]{.smallcaps}, Z.L. and J[in]{.smallcaps}, N.Y. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120, 72

W[eimar]{.smallcaps}, W. *see*[van]{.smallcaps} B[esouw]{.smallcaps}, N.M.

W[ieslander]{.smallcaps}, J. *see* O[hlsson]{.smallcaps}, S.

W[ig]{.smallcaps}, N. *see* V[ajpayee]{.smallcaps}, M.

W[illén]{.smallcaps}, R. *see*Ü[hman]{.smallcaps}, L.

W[ilson]{.smallcaps}, S.N. *see* R[obertson]{.smallcaps}, M.J.

W[ittebole]{.smallcaps}, X., C[oyle]{.smallcaps}, S.M., K[umar]{.smallcaps}, A., G[oshima]{.smallcaps}, M., L[owry]{.smallcaps}, S.F. and C[alvano]{.smallcaps}, S.E. Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating, 99

W[ong]{.smallcaps}, C.K., L[un]{.smallcaps}, S.W.M., K[o]{.smallcaps}, F.W.S., I[p]{.smallcaps}, W.K., H[ui]{.smallcaps}, D.S.C. and L[am]{.smallcaps}, C.W.K. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma, 122

Y[acyshyn]{.smallcaps}, B.R., S[chievella]{.smallcaps}, A., S[ewell]{.smallcaps}, K.L. and T[ami]{.smallcaps}, J.A. Gene polymorphisms and serological markers of patients with active Crohn\'s disease in a clinical trial of antisense to ICAM-1, 141

Y[amada]{.smallcaps}, K. *see* T[subaki]{.smallcaps}, T.

Y[amaguchi]{.smallcaps}, A. *see* N[agahama]{.smallcaps}, K.

Y[amamoto]{.smallcaps}, G. *see* I[wata]{.smallcaps}, T.

Y[amamoto]{.smallcaps}, H. *see* T[subaki]{.smallcaps}, T.

Y[amamoto]{.smallcaps}, S. *see* T[subaki]{.smallcaps}, T.

Y[amamoto]{.smallcaps}, T. *see* K[obayashi]{.smallcaps}, K.

Y[amanaka]{.smallcaps}, S. *see* N[agahama]{.smallcaps}, K.

Y[amasaki]{.smallcaps}, H. *see* S[aitoh]{.smallcaps}, O.

Y[eh]{.smallcaps}, T.M. *see* L[in]{.smallcaps}, Y.S.

Y[en]{.smallcaps}, J.H. *see* L[in]{.smallcaps}, Y.S.

Y[oshie]{.smallcaps}, O. *see* T[subaki]{.smallcaps}, T.

Y[ouinou]{.smallcaps}, P., P[ers]{.smallcaps}, J.-O., S[araux]{.smallcaps}, A. and P[ennec]{.smallcaps}, Y.-L. Viruses contribute to the development of Sjögren\'s syndrome, 19

Z[aichenko]{.smallcaps}, I.Ye. *see* T[alayev]{.smallcaps}, Y.Yu.

Z[argari]{.smallcaps}, A. *see* A[bedi]{.smallcaps}-V[alugerdi]{.smallcaps}, M.

Z[ennaro]{.smallcaps}, C. *see* M[usante]{.smallcaps}, L.

Z[inkernagel]{.smallcaps}, R.M. *see* P[robst]{.smallcaps}, H.C.

Z[uijderwijk]{.smallcaps}, J.M. *see*[van]{.smallcaps} B[esouw]{.smallcaps}, N.M.
